Frequency Therapeutics Profit Margin

Frequency Therapeutics (FREQ) currently reports a profit margin of -4477.08% as of June 2026. That compares with -1779.72% in the prior-year period — down 151.6% year over year. That is below the Healthcare sector average of 13.76%. Use the charts on this page to explore Frequency Therapeutics's profit margin history and peer comparisons.

Frequency Therapeutics's profit margin decreased from -1779.72% to -4477.08% — a 151.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Frequency Therapeutics's profit margin of -4477.08% is lower than the Healthcare sector average of 13.76%. That is roughly 32636.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Frequency Therapeutics's current -4477.08% should be judged against Healthcare norms (sector average: 13.76%) and against FREQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -4477.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.76%. From there, open related valuation or income-statement pages for Frequency Therapeutics, and consider following FREQ for alerts when major investors trade the stock.